LABORATORY NEWS
-
Affidea Acquires A Majority Stake In LabPoint From Lindenhofgruppe, Strengthening Its Diagnostics And Laboratory Medicine Capabilities
Affidea Group, Europe’s leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including oncology, announces the acquisition of a majority stake in LabPoint S.A. from Lindenhofgruppe.
- CancerIQ Unveils A Risk-Based Early Cancer Detection Program For Imaging & Diagnostics
- Labcorp Expands MRD Testing For Breast, Lung And Colon Cancer Recurrence Risk
- HCAP Partners Announces Follow-On Acquisition For Integrated Diagnostic Services (IDS) With The Addition Of Core Analytics Lab & Radiology
- Synthego Announces Entry Into Molecular Biology And Clinical Diagnostic Reagents Market
ARCHIVED NEWSLETTER
- 01.06.26 -- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- 12.23.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- 12.09.25 -- What You Should Know About USP's Bioassay Updates
- 11.25.25 -- Lunit & Labcorp To Advance AI-Powered Digital Pathology Research
- 11.11.25 -- Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards